Financial News
Verve Therapeutics Inc (NQ: VERV )
4.940
+0.100
(+2.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Verve Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/06/15/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/10/Stock-vervetherapeutics-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/15/dominos_pizza_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](/next-assets/images/schema-image-default.png)
Verve Therapeutics's Return On Capital Employed Insights
March 08, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](https://g.foolcdn.com/editorial/images/732173/chalk.jpg)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/13/image_4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ARK_Photo_by_Ira_Lichi_on_Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](https://g.foolcdn.com/editorial/images/721399/dna-genetic-sequencing-biotech-1.jpg)
![](https://g.foolcdn.com/editorial/images/720699/dna-research-concept.jpg)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/02/01/verv_logo_light__275e9401a6b8fe6d5a24270564eff9aa.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2531.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/04/shutterstock_1179311608.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/2a4edc4b-98df-4e32-ade8-159b39872434/small/verve-logo-rgb-color-wtrademark-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2723.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/06/Stock-crispr-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/20/aapharma_11.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/15/image-third_harmonic_bio_.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/713120/gettycelebratingwomanphone.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/07/shutterstock_1926863363.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30794.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.